Determining Whether Probiotics Reduce the Side Effects of Chemotherapy
This study will evaluate whether an oral probiotic protects the gastrointestinal tract from the toxic effects of a chemotherapy drug regimen for dogs.
This study will evaluate whether an oral probiotic protects the gastrointestinal tract from the toxic effects of a chemotherapy drug regimen for dogs.
This study investigates a new therapeutic target (valosin-containing protein) for dogs with lymphoma.
This fellowship investigates genetic lesions in canine mast cell tumors using cytogenetic and expression analysis.
This study investigates the therapeutic relevance of targeting the Wnt signaling pathways in canine malignant melanoma.
The aim of this study is to discover drugs that will work against cancer stem cells of an insulin-producing endocrine pancreatic tumor (insulinoma), thereby improving the prognosis of dogs suffering from insulinoma.
This pilot study will determine the dose and schedule of rapamycin, a promising new adjunct cancer drug.
This study investigates how cytogenetic changes in canine osteosarcoma affect the duration of disease-free interval when patients are treated with amputation followed by doxorubicin and non-cytotoxic suramin.